 Alexander Barker
Concepts (433)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aortic Valve | 68 | 2025 | 359 | 11.580 |
Why?
| | Heart Valve Diseases | 53 | 2024 | 153 | 9.600 |
Why?
| | Hemodynamics | 78 | 2025 | 1100 | 8.220 |
Why?
| | Magnetic Resonance Angiography | 44 | 2025 | 249 | 7.660 |
Why?
| | Aorta | 56 | 2024 | 424 | 7.380 |
Why?
| | Imaging, Three-Dimensional | 56 | 2025 | 569 | 6.130 |
Why?
| | Magnetic Resonance Imaging, Cine | 38 | 2025 | 209 | 5.830 |
Why?
| | Blood Flow Velocity | 76 | 2025 | 412 | 5.550 |
Why?
| | Magnetic Resonance Imaging | 81 | 2025 | 3737 | 5.300 |
Why?
| | Image Interpretation, Computer-Assisted | 30 | 2025 | 278 | 3.980 |
Why?
| | Aorta, Thoracic | 23 | 2023 | 280 | 3.830 |
Why?
| | Aortic Valve Stenosis | 23 | 2025 | 245 | 3.790 |
Why?
| | Aortic Diseases | 23 | 2024 | 119 | 3.760 |
Why?
| | Stress, Mechanical | 33 | 2024 | 489 | 2.830 |
Why?
| | Ventricular Function, Left | 17 | 2025 | 516 | 2.420 |
Why?
| | Predictive Value of Tests | 36 | 2025 | 2075 | 2.140 |
Why?
| | Aortic Aneurysm, Thoracic | 8 | 2023 | 136 | 2.000 |
Why?
| | Regional Blood Flow | 23 | 2025 | 498 | 1.960 |
Why?
| | Pulmonary Artery | 17 | 2024 | 1117 | 1.960 |
Why?
| | Fetal Heart | 4 | 2025 | 56 | 1.920 |
Why?
| | Shear Strength | 15 | 2024 | 68 | 1.870 |
Why?
| | Myocardial Perfusion Imaging | 9 | 2025 | 49 | 1.780 |
Why?
| | Vascular Stiffness | 17 | 2024 | 449 | 1.690 |
Why?
| | Heart Ventricles | 17 | 2024 | 753 | 1.510 |
Why?
| | Echocardiography, Doppler | 5 | 2024 | 113 | 1.460 |
Why?
| | Ventricular Dysfunction, Left | 6 | 2025 | 375 | 1.390 |
Why?
| | Reproducibility of Results | 33 | 2025 | 3356 | 1.350 |
Why?
| | Models, Cardiovascular | 12 | 2021 | 197 | 1.340 |
Why?
| | Image Enhancement | 12 | 2022 | 191 | 1.290 |
Why?
| | Perfusion Imaging | 14 | 2024 | 62 | 1.280 |
Why?
| | Pregnancy Trimester, Third | 3 | 2025 | 117 | 1.230 |
Why?
| | Tetralogy of Fallot | 8 | 2022 | 73 | 1.180 |
Why?
| | Ultrasonography, Prenatal | 4 | 2025 | 291 | 1.170 |
Why?
| | Humans | 195 | 2025 | 141754 | 1.160 |
Why?
| | Heart Valve Prosthesis Implantation | 7 | 2025 | 185 | 1.120 |
Why?
| | Female | 127 | 2025 | 75943 | 1.050 |
Why?
| | Fontan Procedure | 9 | 2025 | 182 | 1.050 |
Why?
| | Echocardiography, Four-Dimensional | 3 | 2024 | 8 | 1.050 |
Why?
| | Heart Defects, Congenital | 13 | 2025 | 884 | 1.010 |
Why?
| | Aortic Coarctation | 8 | 2025 | 80 | 1.010 |
Why?
| | Cardiac-Gated Imaging Techniques | 10 | 2025 | 21 | 0.960 |
Why?
| | Male | 124 | 2025 | 70179 | 0.960 |
Why?
| | Contrast Media | 11 | 2022 | 470 | 0.950 |
Why?
| | Hypertension, Pulmonary | 11 | 2023 | 1942 | 0.940 |
Why?
| | Terminology as Topic | 4 | 2024 | 244 | 0.940 |
Why?
| | Image Processing, Computer-Assisted | 11 | 2025 | 774 | 0.920 |
Why?
| | Gestational Age | 4 | 2025 | 959 | 0.900 |
Why?
| | Adult | 74 | 2025 | 39391 | 0.880 |
Why?
| | Retrospective Studies | 50 | 2025 | 16374 | 0.830 |
Why?
| | Ventricular Function, Right | 12 | 2024 | 283 | 0.810 |
Why?
| | Iothalamic Acid | 1 | 2022 | 5 | 0.780 |
Why?
| | Middle Aged | 65 | 2025 | 34647 | 0.770 |
Why?
| | Observer Variation | 6 | 2023 | 357 | 0.750 |
Why?
| | Coronary Circulation | 10 | 2020 | 136 | 0.750 |
Why?
| | Case-Control Studies | 22 | 2025 | 3597 | 0.710 |
Why?
| | Overweight | 2 | 2025 | 588 | 0.710 |
Why?
| | Young Adult | 41 | 2024 | 13749 | 0.690 |
Why?
| | Pulmonary Circulation | 6 | 2019 | 438 | 0.690 |
Why?
| | Hydrodynamics | 4 | 2022 | 47 | 0.680 |
Why?
| | Sensitivity and Specificity | 15 | 2016 | 1977 | 0.680 |
Why?
| | Cardiac Surgical Procedures | 5 | 2020 | 589 | 0.670 |
Why?
| | Ventricular Dysfunction, Right | 6 | 2022 | 243 | 0.670 |
Why?
| | Problem-Based Learning | 1 | 2021 | 99 | 0.670 |
Why?
| | Child | 44 | 2025 | 22414 | 0.660 |
Why?
| | Electrocardiography | 4 | 2020 | 618 | 0.660 |
Why?
| | Motion Pictures | 1 | 2020 | 20 | 0.660 |
Why?
| | Reference Values | 9 | 2024 | 807 | 0.640 |
Why?
| | Arterial Pressure | 7 | 2019 | 131 | 0.640 |
Why?
| | Tobacco Use | 1 | 2020 | 65 | 0.630 |
Why?
| | Nuclear Physics | 6 | 2014 | 13 | 0.620 |
Why?
| | Tobacco Products | 1 | 2020 | 98 | 0.610 |
Why?
| | Adolescent | 42 | 2025 | 22130 | 0.600 |
Why?
| | Algorithms | 12 | 2025 | 1768 | 0.590 |
Why?
| | Aged | 41 | 2025 | 24746 | 0.580 |
Why?
| | Kidney | 2 | 2025 | 1482 | 0.570 |
Why?
| | Anesthesia | 1 | 2022 | 248 | 0.560 |
Why?
| | Pulse Wave Analysis | 9 | 2023 | 237 | 0.560 |
Why?
| | Severity of Illness Index | 12 | 2025 | 2903 | 0.550 |
Why?
| | Hypoplastic Left Heart Syndrome | 3 | 2024 | 118 | 0.510 |
Why?
| | Models, Theoretical | 7 | 2017 | 584 | 0.500 |
Why?
| | Cardiac Imaging Techniques | 8 | 2021 | 21 | 0.500 |
Why?
| | Aortography | 3 | 2021 | 54 | 0.490 |
Why?
| | Aortic Aneurysm | 6 | 2024 | 70 | 0.490 |
Why?
| | C-Peptide | 2 | 2014 | 167 | 0.480 |
Why?
| | Systole | 9 | 2022 | 175 | 0.460 |
Why?
| | Prospective Studies | 18 | 2024 | 7777 | 0.450 |
Why?
| | Gadolinium DTPA | 2 | 2018 | 71 | 0.450 |
Why?
| | Arteriosclerosis | 2 | 2014 | 83 | 0.450 |
Why?
| | Age Factors | 12 | 2025 | 3294 | 0.440 |
Why?
| | Feasibility Studies | 10 | 2019 | 1027 | 0.420 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2025 | 2537 | 0.420 |
Why?
| | Elementary Particles | 4 | 2014 | 12 | 0.420 |
Why?
| | Cardiovascular Diseases | 7 | 2024 | 2096 | 0.410 |
Why?
| | Aging | 2 | 2015 | 1924 | 0.410 |
Why?
| | Hemorheology | 1 | 2013 | 22 | 0.410 |
Why?
| | Dilatation, Pathologic | 7 | 2024 | 60 | 0.410 |
Why?
| | Stroke Volume | 9 | 2022 | 590 | 0.410 |
Why?
| | Marfan Syndrome | 3 | 2018 | 43 | 0.400 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.400 |
Why?
| | Insulin Antibodies | 1 | 2013 | 103 | 0.400 |
Why?
| | Computer Simulation | 6 | 2021 | 1015 | 0.390 |
Why?
| | Diabetes Mellitus, Type 1 | 6 | 2024 | 3789 | 0.390 |
Why?
| | Norwood Procedures | 2 | 2024 | 29 | 0.390 |
Why?
| | Hyperventilation | 1 | 2012 | 14 | 0.380 |
Why?
| | Insulin-Secreting Cells | 2 | 2014 | 382 | 0.380 |
Why?
| | Pilot Projects | 10 | 2022 | 1826 | 0.350 |
Why?
| | Heart Valve Prosthesis | 4 | 2017 | 118 | 0.350 |
Why?
| | Awareness | 1 | 2012 | 103 | 0.350 |
Why?
| | Acceleration | 1 | 2011 | 36 | 0.350 |
Why?
| | Vascular Remodeling | 5 | 2019 | 196 | 0.340 |
Why?
| | Cross-Sectional Studies | 8 | 2025 | 5697 | 0.340 |
Why?
| | Phantoms, Imaging | 5 | 2022 | 150 | 0.320 |
Why?
| | Mitral Valve Stenosis | 2 | 2022 | 19 | 0.320 |
Why?
| | Child, Preschool | 17 | 2022 | 11512 | 0.320 |
Why?
| | Artifacts | 4 | 2025 | 133 | 0.310 |
Why?
| | Fetus | 2 | 2025 | 802 | 0.310 |
Why?
| | Phenotype | 9 | 2021 | 3177 | 0.300 |
Why?
| | Biomechanical Phenomena | 6 | 2023 | 839 | 0.300 |
Why?
| | Electroencephalography | 1 | 2012 | 524 | 0.300 |
Why?
| | Cerebrovascular Circulation | 2 | 2025 | 271 | 0.290 |
Why?
| | Cardiovascular System | 2 | 2023 | 137 | 0.290 |
Why?
| | Time Factors | 15 | 2025 | 6966 | 0.270 |
Why?
| | Echocardiography | 7 | 2025 | 648 | 0.260 |
Why?
| | Heart Function Tests | 2 | 2019 | 56 | 0.260 |
Why?
| | Ventricular Remodeling | 5 | 2022 | 259 | 0.260 |
Why?
| | Postoperative Complications | 5 | 2020 | 2821 | 0.250 |
Why?
| | Principal Component Analysis | 2 | 2024 | 198 | 0.250 |
Why?
| | Follow-Up Studies | 8 | 2025 | 5212 | 0.250 |
Why?
| | Biomarkers | 8 | 2023 | 4190 | 0.230 |
Why?
| | Cardiorespiratory Fitness | 1 | 2025 | 69 | 0.230 |
Why?
| | Prenatal Diagnosis | 2 | 2025 | 190 | 0.230 |
Why?
| | Renal Circulation | 1 | 2025 | 72 | 0.220 |
Why?
| | Blood Circulation | 1 | 2024 | 44 | 0.220 |
Why?
| | Blood Vessel Prosthesis Implantation | 2 | 2019 | 222 | 0.220 |
Why?
| | Infant, Newborn | 5 | 2023 | 6289 | 0.220 |
Why?
| | Neoplasm, Residual | 1 | 2025 | 132 | 0.220 |
Why?
| | Cross-Over Studies | 2 | 2024 | 582 | 0.220 |
Why?
| | Pulmonary Valve Insufficiency | 2 | 2022 | 42 | 0.220 |
Why?
| | Myocardial Contraction | 3 | 2020 | 303 | 0.220 |
Why?
| | Placental Circulation | 1 | 2025 | 71 | 0.220 |
Why?
| | Viscosity | 3 | 2019 | 93 | 0.220 |
Why?
| | Ultrasonography, Doppler | 1 | 2025 | 122 | 0.220 |
Why?
| | Marketing | 1 | 2024 | 34 | 0.210 |
Why?
| | Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 1 | 2024 | 5 | 0.210 |
Why?
| | Hypoglycemic Agents | 1 | 2013 | 1374 | 0.210 |
Why?
| | Exome | 1 | 2025 | 238 | 0.210 |
Why?
| | Microvessels | 1 | 2025 | 86 | 0.210 |
Why?
| | Rheology | 2 | 2017 | 96 | 0.210 |
Why?
| | Ultrasonography | 3 | 2017 | 761 | 0.210 |
Why?
| | Cardiomyopathy, Hypertrophic | 2 | 2015 | 141 | 0.200 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2025 | 156 | 0.200 |
Why?
| | Arteries | 2 | 2018 | 262 | 0.200 |
Why?
| | Elementary Particle Interactions | 2 | 2013 | 5 | 0.200 |
Why?
| | Carotid Arteries | 2 | 2017 | 201 | 0.200 |
Why?
| | Protein Corona | 1 | 2022 | 5 | 0.200 |
Why?
| | Insulin | 2 | 2013 | 2491 | 0.190 |
Why?
| | Peroneal Neuropathies | 1 | 2022 | 2 | 0.190 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 204 | 0.190 |
Why?
| | Motor Neuron Disease | 1 | 2022 | 21 | 0.190 |
Why?
| | Infant | 10 | 2024 | 9843 | 0.190 |
Why?
| | Radiculopathy | 1 | 2022 | 39 | 0.190 |
Why?
| | Iodine Radioisotopes | 1 | 2022 | 144 | 0.190 |
Why?
| | Respiratory-Gated Imaging Techniques | 3 | 2018 | 10 | 0.190 |
Why?
| | Tomography, X-Ray Computed | 3 | 2023 | 2765 | 0.180 |
Why?
| | Mitral Valve Insufficiency | 1 | 2022 | 73 | 0.180 |
Why?
| | Osseointegration | 1 | 2022 | 71 | 0.180 |
Why?
| | Pregnancy | 6 | 2025 | 7092 | 0.180 |
Why?
| | Biomedical Engineering | 1 | 2021 | 27 | 0.180 |
Why?
| | Oxygen | 2 | 2025 | 992 | 0.180 |
Why?
| | Coronary Vessels | 2 | 2021 | 247 | 0.180 |
Why?
| | Healthy Volunteers | 3 | 2017 | 215 | 0.180 |
Why?
| | Prenatal Care | 1 | 2024 | 303 | 0.180 |
Why?
| | Nanostructures | 1 | 2022 | 114 | 0.180 |
Why?
| | Body Fluids | 1 | 2021 | 70 | 0.180 |
Why?
| | Medicago truncatula | 1 | 2021 | 2 | 0.180 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 1048 | 0.180 |
Why?
| | Anesthesia, General | 1 | 2022 | 117 | 0.170 |
Why?
| | Glomerular Filtration Rate | 2 | 2022 | 752 | 0.170 |
Why?
| | Respiration | 1 | 2022 | 210 | 0.170 |
Why?
| | Cell-Free Nucleic Acids | 1 | 2021 | 33 | 0.170 |
Why?
| | Bioprosthesis | 3 | 2015 | 39 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2025 | 337 | 0.170 |
Why?
| | Lower Extremity | 1 | 2025 | 439 | 0.170 |
Why?
| | Creatinine | 1 | 2022 | 490 | 0.170 |
Why?
| | Glycopeptides | 1 | 2021 | 44 | 0.170 |
Why?
| | Heme | 1 | 2021 | 76 | 0.170 |
Why?
| | Body Surface Area | 1 | 2020 | 36 | 0.160 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2021 | 103 | 0.160 |
Why?
| | Plant Proteins | 1 | 2021 | 112 | 0.160 |
Why?
| | Cardiac Catheterization | 6 | 2023 | 540 | 0.160 |
Why?
| | Aortic Valve Insufficiency | 2 | 2018 | 44 | 0.160 |
Why?
| | Diagnostic Imaging | 2 | 2020 | 327 | 0.160 |
Why?
| | Early Detection of Cancer | 1 | 2025 | 444 | 0.160 |
Why?
| | Sinus of Valsalva | 1 | 2019 | 9 | 0.160 |
Why?
| | Faculty | 1 | 2021 | 154 | 0.160 |
Why?
| | Radiography | 3 | 2024 | 844 | 0.160 |
Why?
| | Intracranial Aneurysm | 1 | 2021 | 100 | 0.160 |
Why?
| | Students, Pharmacy | 1 | 2021 | 105 | 0.160 |
Why?
| | Mechanotransduction, Cellular | 1 | 2021 | 116 | 0.160 |
Why?
| | Anti-Infective Agents | 1 | 2022 | 239 | 0.160 |
Why?
| | Disease Progression | 7 | 2025 | 2800 | 0.150 |
Why?
| | United Kingdom | 1 | 2020 | 322 | 0.150 |
Why?
| | Education, Pharmacy | 1 | 2021 | 133 | 0.150 |
Why?
| | Blood Volume | 2 | 2016 | 65 | 0.150 |
Why?
| | Echocardiography, Doppler, Color | 2 | 2022 | 39 | 0.150 |
Why?
| | Cigarette Smoking | 1 | 2020 | 103 | 0.150 |
Why?
| | Fetal Growth Retardation | 1 | 2025 | 582 | 0.150 |
Why?
| | Transcriptome | 1 | 2025 | 1014 | 0.150 |
Why?
| | Aorta, Abdominal | 2 | 2015 | 48 | 0.150 |
Why?
| | Hemoglobins | 1 | 2021 | 361 | 0.140 |
Why?
| | Elastic Tissue | 1 | 2018 | 10 | 0.140 |
Why?
| | Endothelium, Vascular | 2 | 2016 | 951 | 0.140 |
Why?
| | Neurobehavioral Manifestations | 1 | 1998 | 1 | 0.140 |
Why?
| | Pharmacists | 1 | 2021 | 263 | 0.140 |
Why?
| | Tricuspid Valve | 2 | 2015 | 40 | 0.140 |
Why?
| | Muscarinic Antagonists | 1 | 1998 | 30 | 0.140 |
Why?
| | Placenta | 1 | 2025 | 769 | 0.140 |
Why?
| | Turner Syndrome | 1 | 2018 | 65 | 0.140 |
Why?
| | Hematopoietic Stem Cell Transplantation | 1 | 2024 | 671 | 0.140 |
Why?
| | Anxiety Disorders | 1 | 2021 | 380 | 0.140 |
Why?
| | Prognosis | 7 | 2021 | 4080 | 0.140 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 67 | 0.140 |
Why?
| | Alcoholism | 1 | 2024 | 823 | 0.130 |
Why?
| | Mucocutaneous Lymph Node Syndrome | 1 | 2018 | 91 | 0.130 |
Why?
| | Alcohol Drinking | 1 | 2024 | 835 | 0.130 |
Why?
| | Treatment Outcome | 9 | 2025 | 11181 | 0.130 |
Why?
| | Peptide Fragments | 1 | 2021 | 701 | 0.130 |
Why?
| | Sleep | 1 | 2024 | 885 | 0.130 |
Why?
| | Mesons | 2 | 2014 | 9 | 0.130 |
Why?
| | Heart Transplantation | 1 | 2023 | 715 | 0.130 |
Why?
| | Motion | 3 | 2025 | 101 | 0.130 |
Why?
| | Blood Vessel Prosthesis | 1 | 2017 | 139 | 0.130 |
Why?
| | Blood Pressure | 3 | 2019 | 1748 | 0.130 |
Why?
| | Chorionic Gonadotropin, beta Subunit, Human | 1 | 2016 | 16 | 0.130 |
Why?
| | Cryptorchidism | 1 | 2016 | 16 | 0.120 |
Why?
| | Heart Rate | 1 | 2020 | 821 | 0.120 |
Why?
| | Mitral Valve | 1 | 2017 | 98 | 0.120 |
Why?
| | Thoracic Surgery | 1 | 2018 | 141 | 0.120 |
Why?
| | Endocardium | 1 | 2016 | 31 | 0.120 |
Why?
| | Hypospadias | 1 | 2016 | 31 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 900 | 0.120 |
Why?
| | Statistics, Nonparametric | 2 | 2012 | 434 | 0.120 |
Why?
| | Analysis of Variance | 3 | 2014 | 1321 | 0.120 |
Why?
| | Pregnancy Trimester, First | 1 | 2016 | 139 | 0.120 |
Why?
| | Mitral Valve Annuloplasty | 1 | 2015 | 4 | 0.120 |
Why?
| | Splanchnic Circulation | 1 | 2015 | 12 | 0.120 |
Why?
| | Femoral Artery | 2 | 2013 | 184 | 0.110 |
Why?
| | Cerebrovascular Disorders | 1 | 2016 | 97 | 0.110 |
Why?
| | Preoperative Care | 1 | 2017 | 372 | 0.110 |
Why?
| | Computed Tomography Angiography | 1 | 2016 | 134 | 0.110 |
Why?
| | Angiography | 1 | 2015 | 207 | 0.110 |
Why?
| | Portal Vein | 2 | 2015 | 109 | 0.110 |
Why?
| | Cohort Studies | 5 | 2021 | 5815 | 0.110 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2015 | 38 | 0.110 |
Why?
| | Biomedical Research | 1 | 2021 | 708 | 0.110 |
Why?
| | Coronary Artery Disease | 1 | 2021 | 702 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2013 | 521 | 0.110 |
Why?
| | Neutrons | 1 | 2014 | 10 | 0.110 |
Why?
| | Brain Mapping | 1 | 2017 | 532 | 0.110 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2016 | 228 | 0.110 |
Why?
| | Databases, Factual | 2 | 2017 | 1448 | 0.110 |
Why?
| | Atherosclerosis | 2 | 2021 | 404 | 0.110 |
Why?
| | Ventricular Outflow Obstruction | 1 | 2014 | 41 | 0.110 |
Why?
| | Aged, 80 and over | 5 | 2025 | 7923 | 0.100 |
Why?
| | Heart | 3 | 2023 | 620 | 0.100 |
Why?
| | Subtraction Technique | 1 | 2013 | 25 | 0.100 |
Why?
| | Scleroderma, Systemic | 1 | 2014 | 122 | 0.100 |
Why?
| | Carotid Artery, Internal | 1 | 2013 | 44 | 0.100 |
Why?
| | Endarterectomy, Carotid | 1 | 2013 | 55 | 0.100 |
Why?
| | Consensus | 3 | 2021 | 547 | 0.100 |
Why?
| | Multimodal Imaging | 1 | 2013 | 120 | 0.100 |
Why?
| | Smoking | 1 | 2020 | 1603 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 1 | 2013 | 198 | 0.100 |
Why?
| | Brain | 1 | 2025 | 2868 | 0.100 |
Why?
| | Epilepsy, Partial, Motor | 1 | 2012 | 2 | 0.100 |
Why?
| | Europe | 1 | 2013 | 411 | 0.100 |
Why?
| | Epilepsy, Absence | 1 | 2012 | 9 | 0.100 |
Why?
| | Plaque, Atherosclerotic | 1 | 2013 | 58 | 0.100 |
Why?
| | Protons | 1 | 2013 | 94 | 0.090 |
Why?
| | Carotid Stenosis | 1 | 2013 | 97 | 0.090 |
Why?
| | Vascular Capacitance | 1 | 2012 | 4 | 0.090 |
Why?
| | Age of Onset | 1 | 2013 | 534 | 0.090 |
Why?
| | Fasting | 1 | 2013 | 284 | 0.090 |
Why?
| | Signal-To-Noise Ratio | 2 | 2025 | 67 | 0.090 |
Why?
| | Alzheimer Disease | 1 | 1998 | 595 | 0.090 |
Why?
| | Pulmonary Embolism | 1 | 2014 | 239 | 0.090 |
Why?
| | Systematized Nomenclature of Medicine | 2 | 2021 | 13 | 0.090 |
Why?
| | Surface Properties | 2 | 2022 | 414 | 0.090 |
Why?
| | Endothelial Cells | 1 | 2016 | 816 | 0.080 |
Why?
| | Vasodilation | 1 | 2013 | 516 | 0.080 |
Why?
| | Dilatation | 2 | 2021 | 69 | 0.080 |
Why?
| | Neoplasms | 1 | 2025 | 2747 | 0.080 |
Why?
| | Diastole | 2 | 2020 | 142 | 0.080 |
Why?
| | RNA | 1 | 2016 | 930 | 0.080 |
Why?
| | Longitudinal Studies | 2 | 2014 | 2938 | 0.080 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2013 | 2064 | 0.070 |
Why?
| | Patient-Specific Modeling | 2 | 2020 | 42 | 0.070 |
Why?
| | Swine | 3 | 2016 | 812 | 0.070 |
Why?
| | Risk Factors | 6 | 2020 | 10482 | 0.070 |
Why?
| | Seizures | 1 | 2012 | 442 | 0.070 |
Why?
| | Linear Models | 3 | 2017 | 858 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2016 | 2375 | 0.070 |
Why?
| | Heart-Assist Devices | 1 | 2013 | 562 | 0.070 |
Why?
| | Calibration | 2 | 2017 | 152 | 0.060 |
Why?
| | Peripheral Arterial Disease | 1 | 2013 | 490 | 0.060 |
Why?
| | Prostheses and Implants | 2 | 2022 | 144 | 0.060 |
Why?
| | Sheep | 2 | 2022 | 874 | 0.060 |
Why?
| | Blood Volume Determination | 2 | 2016 | 5 | 0.060 |
Why?
| | Body Mass Index | 1 | 2014 | 2385 | 0.060 |
Why?
| | Myocardial Infarction | 1 | 2013 | 1069 | 0.060 |
Why?
| | Liquid Biopsy | 1 | 2025 | 13 | 0.060 |
Why?
| | Vena Cava, Inferior | 2 | 2016 | 74 | 0.060 |
Why?
| | Elasticity | 2 | 2017 | 194 | 0.060 |
Why?
| | Cardiac Output | 1 | 2025 | 177 | 0.060 |
Why?
| | Stroke | 1 | 2013 | 1158 | 0.050 |
Why?
| | Patient Positioning | 1 | 2025 | 70 | 0.050 |
Why?
| | Organometallic Compounds | 2 | 2018 | 113 | 0.050 |
Why?
| | Gene Expression Profiling | 2 | 2025 | 1771 | 0.050 |
Why?
| | Alcoholic Beverages | 1 | 2024 | 31 | 0.050 |
Why?
| | Neural Conduction | 1 | 2024 | 90 | 0.050 |
Why?
| | Pulsatile Flow | 2 | 2015 | 55 | 0.050 |
Why?
| | Technology | 1 | 2024 | 94 | 0.050 |
Why?
| | Actigraphy | 1 | 2024 | 126 | 0.050 |
Why?
| | Animals | 8 | 2022 | 37749 | 0.050 |
Why?
| | Risk Assessment | 3 | 2018 | 3508 | 0.050 |
Why?
| | Bromocriptine | 1 | 2022 | 31 | 0.050 |
Why?
| | Exercise Tolerance | 1 | 2025 | 280 | 0.050 |
Why?
| | Fasciculation | 1 | 2022 | 2 | 0.050 |
Why?
| | Durapatite | 1 | 2022 | 36 | 0.050 |
Why?
| | Adsorption | 1 | 2022 | 154 | 0.050 |
Why?
| | Exercise Test | 1 | 2025 | 624 | 0.050 |
Why?
| | Blood Pressure Determination | 2 | 2013 | 145 | 0.050 |
Why?
| | Oxygen Consumption | 1 | 2025 | 715 | 0.050 |
Why?
| | Prevalence | 2 | 2023 | 2799 | 0.050 |
Why?
| | Titanium | 1 | 2022 | 85 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 16 | 0.040 |
Why?
| | Cell Adhesion | 1 | 2022 | 469 | 0.040 |
Why?
| | Histidine | 1 | 2021 | 65 | 0.040 |
Why?
| | Blood Proteins | 1 | 2022 | 250 | 0.040 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2023 | 614 | 0.040 |
Why?
| | Collagen | 1 | 2023 | 460 | 0.040 |
Why?
| | Stents | 2 | 2015 | 531 | 0.040 |
Why?
| | Sex Factors | 2 | 2017 | 2063 | 0.040 |
Why?
| | Longevity | 1 | 2022 | 175 | 0.040 |
Why?
| | Printing, Three-Dimensional | 1 | 2021 | 93 | 0.040 |
Why?
| | Diabetic Cardiomyopathies | 1 | 2020 | 34 | 0.040 |
Why?
| | Heart Failure | 1 | 2013 | 2093 | 0.040 |
Why?
| | Electromyography | 1 | 2022 | 411 | 0.040 |
Why?
| | Biological Transport | 1 | 2021 | 410 | 0.040 |
Why?
| | Electrophysiological Phenomena | 1 | 2019 | 58 | 0.040 |
Why?
| | Machine Learning | 1 | 2025 | 556 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 594 | 0.040 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 2020 | 147 | 0.040 |
Why?
| | Obesity | 2 | 2023 | 3008 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1989 | 0.040 |
Why?
| | Self Concept | 1 | 2021 | 262 | 0.040 |
Why?
| | Perfusion | 2 | 2017 | 228 | 0.040 |
Why?
| | Mechanical Phenomena | 1 | 2019 | 85 | 0.040 |
Why?
| | User-Computer Interface | 1 | 2019 | 164 | 0.040 |
Why?
| | Gadolinium | 1 | 2018 | 81 | 0.040 |
Why?
| | Models, Biological | 1 | 2006 | 1828 | 0.040 |
Why?
| | Myocardium | 1 | 2023 | 928 | 0.040 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2017 | 17 | 0.030 |
Why?
| | Anastomosis, Surgical | 1 | 2018 | 159 | 0.030 |
Why?
| | Vascular Resistance | 1 | 2019 | 364 | 0.030 |
Why?
| | Liver Transplantation | 2 | 1994 | 768 | 0.030 |
Why?
| | Preoperative Period | 1 | 2017 | 144 | 0.030 |
Why?
| | Vena Cava, Superior | 1 | 2016 | 22 | 0.030 |
Why?
| | Genomic Library | 1 | 2016 | 17 | 0.030 |
Why?
| | DNA Methylation | 1 | 2021 | 648 | 0.030 |
Why?
| | Reaction Time | 1 | 1998 | 432 | 0.030 |
Why?
| | Memory | 1 | 1998 | 263 | 0.030 |
Why?
| | Tissue Inhibitor of Metalloproteinases | 1 | 2015 | 19 | 0.030 |
Why?
| | Extracellular Fluid | 1 | 2015 | 35 | 0.030 |
Why?
| | Liver Circulation | 1 | 2015 | 11 | 0.030 |
Why?
| | Risk | 1 | 2018 | 907 | 0.030 |
Why?
| | Elastin | 1 | 2015 | 79 | 0.030 |
Why?
| | Splenic Artery | 1 | 2015 | 16 | 0.030 |
Why?
| | Australia | 1 | 2016 | 311 | 0.030 |
Why?
| | Mesenteric Artery, Superior | 1 | 2015 | 22 | 0.030 |
Why?
| | Pedigree | 1 | 2016 | 511 | 0.030 |
Why?
| | Hepatic Artery | 1 | 2015 | 52 | 0.030 |
Why?
| | Heart Atria | 1 | 2016 | 139 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2015 | 95 | 0.030 |
Why?
| | Energy Metabolism | 1 | 2021 | 932 | 0.030 |
Why?
| | Protein Binding | 1 | 2021 | 2242 | 0.030 |
Why?
| | Cytokines | 1 | 2022 | 2100 | 0.030 |
Why?
| | ROC Curve | 1 | 2016 | 590 | 0.030 |
Why?
| | Postoperative Period | 1 | 2015 | 361 | 0.030 |
Why?
| | Organ Preservation Solutions | 1 | 1994 | 45 | 0.030 |
Why?
| | Cell Count | 1 | 2014 | 326 | 0.030 |
Why?
| | Electrons | 1 | 2014 | 88 | 0.030 |
Why?
| | Organ Sparing Treatments | 1 | 2013 | 36 | 0.030 |
Why?
| | Prosthesis Design | 1 | 2015 | 339 | 0.030 |
Why?
| | Organ Preservation | 1 | 1994 | 112 | 0.030 |
Why?
| | Observational Studies as Topic | 1 | 2013 | 124 | 0.020 |
Why?
| | Pericardium | 1 | 2013 | 58 | 0.020 |
Why?
| | Quality Control | 1 | 2013 | 171 | 0.020 |
Why?
| | Cyclosporine | 1 | 1994 | 265 | 0.020 |
Why?
| | Tacrolimus | 1 | 1994 | 198 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 1972 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1866 | 0.020 |
Why?
| | Silicones | 1 | 2012 | 26 | 0.020 |
Why?
| | Thermodynamics | 1 | 2014 | 424 | 0.020 |
Why?
| | Compliance | 1 | 2012 | 50 | 0.020 |
Why?
| | Sus scrofa | 1 | 2012 | 60 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2015 | 1498 | 0.020 |
Why?
| | Forecasting | 1 | 2013 | 384 | 0.020 |
Why?
| | Recurrence | 1 | 2015 | 1111 | 0.020 |
Why?
| | Meglumine | 1 | 2011 | 17 | 0.020 |
Why?
| | Abnormalities, Multiple | 1 | 2012 | 197 | 0.020 |
Why?
| | United States | 2 | 2018 | 15310 | 0.020 |
Why?
| | Heart Diseases | 1 | 2013 | 335 | 0.020 |
Why?
| | Equipment Design | 1 | 2012 | 525 | 0.020 |
Why?
| | Cognition | 1 | 1998 | 1228 | 0.020 |
Why?
| | Pyocyanine | 1 | 1989 | 2 | 0.020 |
Why?
| | Phenazines | 1 | 1989 | 12 | 0.020 |
Why?
| | Mucociliary Clearance | 1 | 1989 | 45 | 0.020 |
Why?
| | Trachea | 1 | 1989 | 255 | 0.020 |
Why?
| | Scattering, Radiation | 1 | 2006 | 101 | 0.010 |
Why?
| | Microbubbles | 1 | 2006 | 49 | 0.010 |
Why?
| | Liver | 1 | 1994 | 1820 | 0.010 |
Why?
| | Nanotubes | 1 | 2006 | 46 | 0.010 |
Why?
| | Mice | 1 | 2022 | 18109 | 0.010 |
Why?
| | Particle Size | 1 | 2006 | 404 | 0.010 |
Why?
| | Cardioplegic Solutions | 1 | 1994 | 6 | 0.010 |
Why?
| | Raffinose | 1 | 1994 | 29 | 0.010 |
Why?
| | Allopurinol | 1 | 1994 | 68 | 0.010 |
Why?
| | Adenosine | 1 | 1994 | 253 | 0.010 |
Why?
| | Glutathione | 1 | 1994 | 362 | 0.010 |
Why?
| | Graft Survival | 1 | 1994 | 502 | 0.010 |
Why?
| | Tissue and Organ Procurement | 1 | 1994 | 317 | 0.010 |
Why?
| | Guinea Pigs | 1 | 1989 | 171 | 0.000 |
Why?
|
|
Barker's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|